Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART

OBJECTIVES: The WHO recently recommended the use of a new first-line ART containing dolutegravir. We investigated the efficacy of NRTI backbones (tenofovir or abacavir with a cytosine analogue) in low- and middle-income countries where there is significant prior exposure to antiretrovirals and drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Derache, Anne, Iwuji, Collins C, Danaviah, Siva, Giandhari, Jennifer, Marcelin, Anne-Geneviève, Calvez, Vincent, de Oliveira, Tulio, Dabis, François, Pillay, Deenan, Gupta, Ravindra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337894/
https://www.ncbi.nlm.nih.gov/pubmed/30380053
http://dx.doi.org/10.1093/jac/dky428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337894/
https://www.ncbi.nlm.nih.gov/pubmed/30380053
http://dx.doi.org/10.1093/jac/dky428

Ejemplares similares